Organon Pharma Indonesia Tbk. vs Sejahteraraya Anugrahjaya Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Sejahteraraya Anugrahjaya Tbk. trades at Rp15,600 (market cap 159.11T, 10.1K 24h volume). The key difference: Sejahteraraya Anugrahjaya Tbk. is far larger — about 1524× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SRAJ | |
|---|---|---|
Market Cap | 104.4B | 159.11T |
Volume | — | 10.1K |
Lot | — | 101 |
Turnover | — | 147.99M |
Average Price | — | 14,652.23 |
Value | — | 147.99M |
Indicative Equilibrium Price | — | 15,600 |
Indicative Equilibrium Volume | — | 59 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Sejahteraraya Anugrahjaya (the Company) was established based on Notarial Deed of Misahardi SH. No. 210 dated May 20, 1991, and has been improved based on Notarial Deed. No. 200 of the same notary, dated December 11, 1992. The company commenced its operations on July 1995. The companys articles of association have been change several times, the latest was based on Extraordinary Resolution of Shareholders stated on Notarial Deed No. 145 dated June 17, 2011 of Buntario Tigris, SH regarding the increase on capital stock and issued.
Read more on SRAJ →